SOLVENTUM CORP (SOLV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SOLV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SOLV | CEO, The T1D Fund; Former EVP, Strategy & Business Development, Bristol-Myers Squibb Inc.; Director | 58 | ["CEO, The T1D Fund", "Former EVP, Strategy & Business Development, Bristol-Myers Squibb Inc.", "Extensive experience as an executive in the healthcare industry", "Significant strategy and corporate development skills", "Oversaw significant revenue growth and cost savings", "Strategic business development and partnership activities", "Numerous mergers and acquisitions experience", "Master of Science in Foreign Service from Georgetown University", "Bachelor of Arts in German Literature and European History from Ohio State University", "Fulbright Scholar to the Universities of Cologne and Hamburg"] | ["AC", "STQC", "Audit", "Science, Technology and Quality"] | 2026 |
Biography sourced from the proxy statement filing.
Professional experience The T1D Fund Chief Executive Officer (2025 present) Bristol-Myers Squibb Executive Vice President, Strategy & Business Development (2020 2024) Barclays plc Managing Director (2010 2020) Thermo Fisher Scientific Senior Vice President (2009 2010) Goldman Sachs Group, Inc. (1993 2009) Managing Director, Senior Coverage Officer - Health Care Elizabeth A. Mily 58 Director since 2024 Board committees Audit; Science, Technology and Quality Other directorships and memberships Ampersand Biomedicines (director) (2024 - Present) Skills and experience supporting nomination Ms. Mily brings extensive experience as an executive in the healthcare industry as well as significant strategy and corporate development skills to the Board. During her previous roles, Ms. Mily oversaw significant revenue growth and cost savings, strategic business development and partnership activities, as well as numerous mergers and acquisitions, including divestitures. Ms. Mily holds a Master of Science in Foreign Service from Georgetown University and a Bachelor of Arts in German Literature and European History from the Ohio State University. She was also a Fulbright Scholar to the Universities of Cologne and Hamburg, Germany. Healthcare Industry Significant experience in multiple leadership roles at healthcare and healthcare advisory companies Executive Leadership Experience in increasingly significant executive leadership and Chief Executive Officer positions Financial Acumen & Experience Executive experience involving financial management of healthcare companies and as managing director in healthcare investment banking International & Global Operations Service in senior executive roles at global healthcare companies Strategy & M&A Substantial experience in guiding healthcare companies undergoing significant transitions, including numerous significant M&A transactions, partnerships, and major investments and managed alliances Science, Technology, Research & Innovation Management experience in selection, development and regulatory clearance for innovation and new product decisions Risk Management Risk oversight experience particularly in portfolio and transaction management Human Capital Management Experience with leadership of large teams, particularly in performance, advancement, and compensation management